Non-dilutive funding is capital that doesn't require giving up equity or ownership. The 12 main types for tech startups include SBIR/STTR grants ($175K-$2.1M per phase), R&D tax credits (up to $500K/year), revenue-based financing, state grants, foundation grants, prize competitions, and more. Over $4 billion in SBIR funding alone is available annually. This guide covers every option, what each actually pays, and how to stack them.
Most "non-dilutive funding" content on the internet is written by fintech companies that want to sell you a loan, or VCs explaining why you should take their money instead. This is written by a grant consulting firm. We're biased toward grants, and we'll be upfront about that. But we'll cover the full landscape honestly.
Every non-dilutive funding type, compared
| Funding Type | Typical Amount | Dilution | Speed | Effort | Competition | Best Stage |
|---|---|---|---|---|---|---|
| SBIR/STTR Phase I | $175K-$314K | None | 3-9 months | High | High (15-20% win) | Pre-seed to Seed |
| SBIR/STTR Phase II | $600K-$2.1M | None | 6-12 months | High | Medium (~40-60% win) | Seed to Series A |
| DARPA / ARPA-H / BARDA | $50K-$20M | None | 3-12 months | Very high | Very high | Seed to Series B |
| DOE ARPA-E | $500K-$9M | None | 6-12 months | Very high | Very high | Seed to Series A |
| State innovation grants | $25K-$100K | None | 1-3 months | Low-Medium | Medium | Pre-seed to Seed |
| Foundation grants | $10K-$500K | None | 3-6 months | Medium | High | Pre-seed to Series A |
| Prize competitions | $10K-$100M+ | None | 6-24 months | Medium-High | Very high | Any |
| R&D tax credit (US) | Up to $500K/yr | None | At tax filing | Low-Medium | None (entitlement) | Any with R&D spend |
| SR&ED (Canada) | 35% of up to $6M R&D | None | 45-120 days | Medium | None (entitlement) | Any with Canadian R&D |
| IRAP (Canada) | $200K-$1M | None | 3-6 months | Medium | Medium | Pre-seed to Series A |
| Revenue-based financing | $10K-$20M | None | Days to weeks | Low | Low (revenue-qualified) | Post-revenue |
| Venture debt | ~30% of last raise | Minimal (warrants) | 4-8 weeks | Medium | Low-Medium | Post-VC (Seed+) |
| OTAs / DIU contracts | $100K-$50M+ | None | 60-120 days | High | High | Seed to Series B |
| Fellowships | $1K-$200K | None | 1-3 months | Low-Medium | High | Pre-seed |
The rest of this guide breaks down each category with the specifics you need to decide what's worth pursuing.
Government grants: the biggest pool most startups ignore
SBIR/STTR
SBIR is the flagship. Eleven federal agencies set aside a combined $4B+ annually for R&D at small businesses. It's the single largest source of non-dilutive capital for US tech startups.
The structure is phased:
- Phase I: $175K-$314K (feasibility, 6-12 months)
- Phase II: $600K-$2.1M (full R&D, 24 months)
- Phase III: Sole-source government contract (no funding ceiling, no additional competition)
The three biggest agencies are DoD ($2.3B annually), NIH ($1.2B), and NSF (~$174M). If your technology is defense-relevant, biomedical, or broadly scientific/engineering, one of those three is almost certainly where you should start.
Success rates run about 15-25% for Phase I depending on agency. First-time applicants without a track record face steeper odds -- closer to 10-15% at competitive agencies like NIH. The learning curve is real but the payoff is substantial -- $2.4M+ through Phase II with zero dilution, plus the validation signal that research shows roughly doubles subsequent VC probability.
For the full breakdown, see our SBIR guide for startups and funding amounts by agency.
2026 update: SBIR was reauthorized through 2031 after a brief lapse. New Strategic Breakthrough Awards of up to $30M are available for Phase II alumni with matching funds.
Beyond SBIR: advanced federal programs
If your technology is genuinely breakthrough, several federal programs offer larger awards outside the standard SBIR structure:
DARPA BAAs (Broad Agency Announcements) fund high-risk, high-payoff research. No fixed amounts -- proposals can range from $100K to $10M+ depending on the technical approach. DARPA wants solutions to hard problems, not incremental improvements. The application process is different from SBIR (respond to specific BAAs, not fixed solicitations). Worth noting: DARPA typically funds university labs and established defense contractors. Pre-seed startups can win, but it's rare without a prior relationship with a program manager. Most startups should start with SBIR. See our DARPA BAA guide.
ARPA-H funds health technology breakthroughs. Accelerator programs (like DRIVe) start at $50K-$200K; full awards can reach $20M. If you're building novel therapeutics, diagnostics, or health platforms, ARPA-H is worth exploring alongside NIH SBIR.
BARDA (Biomedical Advanced Research and Development Authority) funds medical countermeasures -- biodefense, pandemic preparedness, antimicrobial resistance, diagnostics. Accelerator hubs provide $50K-$200K; full awards reach $20M+. Narrower scope than ARPA-H but deeper funding for companies in its lane.
DOE ARPA-E funds transformative energy technology. Awards average $2-3M over 3 years. SPARKS awards start at $500K for earlier-stage concepts. If you're in clean energy, grid technology, or energy storage, ARPA-E is the most ambitious funder in the space.
State innovation grants
Every state has some form of innovation funding, though quality and amounts vary enormously. Typical awards are $25K-$100K -- smaller than federal grants but faster and less competitive.
The best state programs for tech startups:
- SBIR matching programs: Several states (Illinois, California, Minnesota, and others) match federal SBIR awards dollar-for-dollar, effectively doubling your Phase I. Check your state's SBIR support office.
- Direct state grants: California CalSeed (clean energy, up to $150K), New York Innovate NY (up to $150K for tech startups), Minnesota DEED Launch grants, Kansas Community Empowerment initiative, and similar programs in most states with active tech ecosystems.
- FAST programs: Federally funded, state-administered programs that help companies prepare SBIR applications. Free coaching, not direct funding.
OTAs and DIU contracts
OTAs (Other Transaction Agreements) are government contracts that bypass traditional procurement rules -- faster and more startup-friendly than standard federal contracts. DIU (Defense Innovation Unit) is the Pentagon's tech accelerator that buys commercial technology for military use.
- Amounts: $100K to $50M+ (prototype through production)
- Speed: DIU targets 60-90 days from problem to prototype award; NSTXL (a consortium that manages OTAs) averages 120 days
- No FAR compliance required -- which removes the bureaucratic overhead that keeps most startups away from government contracts
- 80%+ of DIU awards go to small businesses
If you're building dual-use technology (useful for both commercial and defense markets), OTAs are one of the fastest paths from "interesting tech" to "government revenue." The trade-off: defense focus, and some cost-sharing may be required.
State grants are stackable with federal grants and tax credits. They're also a good place to start if federal SBIR feels too competitive for your first attempt.
Foundation grants and prize competitions
Foundation grants
Most foundation grants go to nonprofits, but a small number fund for-profit companies with genuine social impact alignment. The amounts are modest ($10K-$500K) and the eligibility is narrow.
Worth exploring if your technology has a clear social mission:
- RWJF (Robert Wood Johnson Foundation): health equity and health technology
- FFAR (Foundation for Food & Agriculture Research): food and ag-tech (requires 1:1 matching funds -- pre-seed companies often can't meet this)
- Gates Foundation: global health, agriculture, education (occasional for-profit funding)
- Kauffman Foundation: entrepreneurship and economic development
Important caveats: many foundations are invite-only (don't waste time on those), matching fund requirements can be prohibitive for early-stage companies, and the application process can be as heavy as federal grants for much smaller amounts. Foundation grants are a complement to your strategy, not the core.
Prize competitions
Prize competitions fund results, not proposals. You build something, compete, and winners get paid. No equity, no cost share (usually), and strong publicity value.
- XPRIZE: Large-scale challenges ($1M-$100M+ purses). Active competitions include Wildfire ($11M), Healthspan ($101M by 2030), and Feed the Next Billion.
- DOE American-Made Challenges: Administered through NREL, zero cost share, low barrier to entry. Multiple active challenges in energy, manufacturing, and climate.
- Challenge.gov: Federal portal aggregating prize competitions across all agencies. Browse by topic area.
The economics of prizes are different from grants: winner-take-all dynamics mean the expected value is lower unless you're genuinely competitive. But if you have a working prototype in a challenge domain, the ROI can be exceptional -- cash plus publicity.
R&D tax credits: the non-dilutive funding hiding in your tax return
This is the most underused source of non-dilutive capital for startups, because most founders don't realize they qualify.
US Federal R&D Tax Credit (Section 41)
If your startup spends money on R&D -- and as a tech company, you almost certainly do -- you're likely eligible for the federal R&D tax credit. For startups, the key provision:
- Payroll tax offset: Companies with less than $5M in gross receipts (and no receipts in 5+ prior years) can apply up to $500,000 per year against payroll taxes. This works even if you have no income tax liability -- which is most pre-profit startups.
2025 law change: Congress restored immediate expensing of domestic R&D (reversing the problematic 2022 requirement to amortize R&D costs over 5 years). This is a big deal for startup cash flow.
Many states offer additional R&D credits (5-15% of qualified expenses) on top of the federal credit. Check your state's program.
The effort is relatively low -- your accountant or an R&D tax credit specialist handles it. The documentation requirements are real (you need to track qualified activities), but for a tech startup doing genuine R&D, the default should be "claim it."
Canadian SR&ED
If you have a Canadian entity doing R&D in Canada, SR&ED (Scientific Research and Experimental Development) is one of the most generous innovation tax credits in the world:
- 35% enhanced refundable credit on the first $6M of eligible R&D expenditures for CCPCs (Canadian-Controlled Private Corporations)
- Maximum cash refund: up to $2.1M per year
- Refundable -- you get cash back even with no tax liability
- 2026 changes: CRA targeting 45-day processing for non-reviewed claims; the eligible expenditure limit was proposed to increase to $6M in the 2024 federal budget (pending final legislation -- confirm with your accountant before planning around this)
SR&ED stacks with IRAP. Together they can offset 60%+ of Canadian R&D costs. See our IRAP vs. SBIR comparison for the full cross-border picture.
Revenue-based financing and venture debt
These are the non-dilutive options for companies that already have revenue or have raised equity.
Revenue-based financing (RBF)
RBF providers give you capital in exchange for a percentage of future monthly revenue until a repayment cap (typically 1.5-3x the funded amount).
- Amounts: $10K-$20M
- Speed: Days to weeks (fastest non-dilutive option)
- Requirements: $10K-$50K+ monthly recurring revenue
- Providers: Lighter Capital, Pipe, Capchase, Clearco, Arc, Gilion
Pros: No equity, payments flex with revenue, fast. Cons: requires revenue (not for pre-revenue), total cost can be high (1.5-3x), reduces monthly cash flow. Best for post-revenue SaaS companies that want to extend runway without dilution.
Venture debt
Venture debt provides a loan (typically ~30% of your last equity raise) with interest and small warrant coverage.
- Terms: 8-15% interest, 2-4 year maturity, 6-12 month interest-only period, 0.5-1.5% warrant coverage
- Speed: 4-8 weeks to close
- Requirements: Prior VC backing (typically post-seed or post-Series A)
Venture debt is minimally dilutive (the warrants), not truly non-dilutive. But it's fast, it extends runway between equity rounds, and the dilution is a fraction of what another equity round would cost. Best as a complement to VC, not a replacement.
How to stack non-dilutive funding by stage
The real power of non-dilutive funding is stacking multiple sources. Here's what a strategic capital stack looks like at each stage:
Pre-seed (no revenue, no VC)
- R&D tax credit (payroll offset, up to $500K/year) -- claim it from day one
- State grants ($25K-$100K) -- lowest competition, fastest turnaround
- NSF SBIR Project Pitch (3-4 hours, $305K if invited and funded)
- SR&ED + IRAP if you have a Canadian entity
- Potential stack: $300K-$800K non-dilutive before any equity round
Seed (some traction, may have raised angels)
- SBIR Phase I ($175K-$314K) at the agency matching your technology
- State SBIR matching (dollar-for-dollar in eligible states)
- R&D tax credits (federal + state)
- Foundation grants if you have social impact alignment
- Potential stack: $500K-$1.5M non-dilutive alongside or before seed equity
Series A (product-market fit emerging)
- SBIR Phase II ($600K-$2.1M)
- Revenue-based financing ($100K-$5M if you have recurring revenue)
- Venture debt (30% of your raise)
- DARPA / OTAs if defense-relevant
- R&D tax credits (often larger at this stage as R&D spend grows)
- Potential stack: $1M-$5M+ non-dilutive alongside Series A equity
The companies that are most strategic about this don't choose between dilutive and non-dilutive. They use non-dilutive capital to de-risk R&D and extend runway, then raise equity from a position of strength.
Fellowships and grant hybrids
A small but interesting category for young or unconventional founders:
- Thiel Fellowship: $100K-$200K over 2 years for founders under 22 willing to leave or skip college
- Emergent Ventures (Mercatus Center): $1K-$50K for "zero to one" ideas, rolling applications, open to anyone 13+
- 1517 Fund: invests in student and dropout founders
These are niche, but if you're eligible, the application effort is low and the signal value is high.
The bottom line
Non-dilutive funding isn't a niche strategy. It's a core part of a smart capital stack. The $4B+ annual SBIR program alone dwarfs most seed-stage VC funds. R&D tax credits are effectively free money for work you're already doing. And the validation signal from a competitive federal grant makes your next equity round easier, not harder.
The founders who leave money on the table are the ones who think of grants as "nice to have" instead of as a strategic capital source. Don't be one of them.
Want to know which non-dilutive programs fit your startup?
The stacking strategies in this guide are real -- but which ones apply to your specific technology and stage is a conversation, not a 12-hour research project. We specialize in the grant side of this landscape -- SBIR, DARPA, NSF, NIH, and cross-border programs (IRAP, SR&ED). Our Strategy Review maps the non-dilutive opportunities that are actually realistic for your company.